New HSP90-CDC37 protein-protein interaction inhibitors with antitumor in vitro and in vivo efficacy Feb. 18, 2021
A regulator of ER proteostasis shows promising antiviral activity against dengue and Zika viruses Feb. 18, 2021
Pfizer begins pivotal phase II study of elranatamab in relapsed or refractory multiple myeloma Feb. 17, 2021
RSS